Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, ...

Every year, sepsis kills roughly 350,000 adults in the United States alone, according to the Centers for Disease Control and ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiorit ...

In this Q&A, Mwango Kashoki, MD, MPH, SVP and global head of regulatory strategy at Parexel, breaks down the FDA's plausible ...

PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...

High blood pressure is the main modifiable risk factor for preventing cardiovascular events in people who have had a stroke or transient ischaemic attack; however, only approximately one in three ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

Patient- and physician-facing interventions together doubled the reductions in PPI use ...

An HHS spokesperson said Dr. Jay Bhattacharya had concerns about the paper’s methodology. Some current or former CDC ...

The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Abstract: Safety and data efficiency are important concerns in data-driven control, especially for nonlinear systems with unknown dynamics and subject to disturbances. In this work, we consider a ...

The impact of intensive blood pressure (BP) control on cognitive function in East Asian populations remains uncertain. We aimed to assess the effect of a lower systolic BP target on global cognitive ...